Project lightspeed: A case study in research ethics and accelerated vaccine development

Research Ethics 20 (4):847-856 (2024)
  Copy   BIBTEX

Abstract

The COVID-19 pathogen led to a fast expanding pandemic because it proved lethal in certain populations but could be transmitted by persons who appeared healthy. As a result, researchers came under unprecedented time pressure to develop a vaccine. This case study focuses on the first COVID-19 vaccine, which was approved for use in humans, known as Comirnaty, the BioNTech-Pfizer COVID-19 vaccine or Vaccine BNT162b2. With the benefit of hindsight, we show how close collaboration with regulators and trust-based decisions meant that the race for a COVID-19 vaccine was won without purposefully infecting healthy participants with an infectious agent that can cause severe illness or death and for which no rescue therapy had existed.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 103,486

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Ethical allocation of future COVID-19 vaccines.Rohit Gupta & Stephanie R. Morain - 2021 - Journal of Medical Ethics 47 (3):137-141.

Analytics

Added to PP
2024-05-02

Downloads
11 (#1,471,665)

6 months
3 (#1,096,948)

Historical graph of downloads
How can I increase my downloads?